Mineralys Therapeutics, Inc.
Nasdaq: MLYSPharmaceutical Preparations · Entity-resolved by Clous
CIK0001933414
TickerMLYS
ExchangeNasdaq
SIC2834
StateDE
FY end12-31
Illustrative profile — live data lights up when a server API key is configured.
Key financials
Revenue
—
—
Net IncomeFY2025-12-31
-$154.65M
+13.0% YoY
Total AssetsFY2025-12-31
$661.81M
+221.4% YoY
EquityFY2025-12-31
$646.69M
+238.1% YoY
Shares OutstandingFY2025-12-31
82.4M
—
Operating Cash FlowFY2025-12-31
-$142.42M
+14.4% YoY
Short interest & fails
Short-sale volume
FINRA Reg SHO · daily27.3%
short of total volume · 2026-06-18
2026-06-1827.3%
2026-06-1733.3%
2026-06-1626.8%
2026-06-159.8%
2026-06-1258.3%
Fails-to-deliver
SEC CNS fails · semi-monthly3
shares failed · 2026-05-22
2026-05-223 sh$30.23
2026-04-246.06K sh$28.49
2026-04-2241 sh$28.78
2026-04-208.26K sh$30.58
2026-04-09170 sh$27.76
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|
| Net Income | -$71.9M | -$177.81M | -$154.65M | +13.0% | — |
| Total Assets | $251.64M | $205.9M | $661.81M | +221.4% | — |
| Equity | $241.15M | $191.26M | $646.69M | +238.1% | — |
| Operating Cash Flow | -$81.17M | -$166.31M | -$142.42M | +14.4% | — |
| Shares Outstanding | — | — | 82.4M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001933414